A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 1, 2013, Pages 192-197

  Habra, Mouhammed Amir ^a   Ejaz, Shamim ^a   Feng, Lei ^a   Das, Prajnan ^a   Deniz, Ferhat ^a   Grubbs, Elizabeth G ^a   Phan, Alexandria ^a   Waguespack, Steven G ^a   Ayala Ramirez, Montserrat ^a   Jimenez, Camilo ^a   Perrier, Nancy D ^a   Lee, Jeffrey E ^a   Vassilopoulou Sellin, Rena ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOTANE;

ADRENAL CORTEX CARCINOMA; ADRENALECTOMY; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT OUTCOME;

ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADRENOCORTICAL CARCINOMA; ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872076027     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2367     Document Type: Article

References (27)

1. Paton BL, Novitsky YW, Zerey M, Harrell AG, Norton HJ, Asbun H, Kercher KW, Heniford BT 2006 Outcomes of adrenal cortical carcinoma in the United States. Surgery 140:914-920
2. Bilimoria KY, Shen WT, Elaraj D, Bentrem DJ, Winchester DJ, Kebebew E, Sturgeon C 2008 Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer 113:3130-3136
3. Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M, Worden FP 2005 Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 12:667-680
4. Fassnacht M, Libé R, Kroiss M, Allolio B 2011 Adrenocortical carcinoma: a clinician's update. Nat Rev Endocrinol 7:323-335
5. Icard P, Goudet P, Charpenay C, Andreassian B, Carnaille B, Chapuis Y, Cougard P, Henry JF, Proye C 2001 Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg 25:891-897
6. Dackiw AP, Lee JE, Gagel RF, Evans DB 2001 Adrenal cortical carcinoma. World J Surg 25:914-926
7. Brix D, Allolio B, Fenske W, Agha A, Dralle H, Jurowich C, Langer P, Mussack T, Nies C, Riedmiller H, Spahn M, Weismann D, Hahner S, Fassnacht M 2010 Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients. Eur Urol 58:609-615
8. Porpiglia F, Fiori C, Daffara F, Zaggia B, Bollito E, Volante M, Berruti A, Terzolo M 2010 Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer. Eur Urol 57:873-878
9. Gonzalez RJ, Shapiro S, Sarlis N, Vassilopoulou-Sellin R, Perrier ND, Evans DB, Lee JE 2005 Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. Surgery 138:1078-1085; discussion 1085-1076
10. Miller BS, Ammori JB, Gauger PG, Broome JT, Hammer GD, Doherty GM 2010 Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma. World J Surg 34:1380-1385
11. Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, Rossetto R, Buci L, Sperone P, Grossrubatscher E, Reimondo G, Bollito E, Papotti M, Saeger W, Hahner S, Koschker AC, Arvat E, Ambrosi B, Loli P, Lombardi G, Mannelli M, Bruzzi P, Mantero F, Allolio B, Dogliotti L, Berruti A 2007 Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med 356:2372-2380
12. Berruti A, Fassnacht M, Baudin E, Hammer G, Haak H, Leboulleux S, Skogseid B, Allolio B, Terzolo M 2010 Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel. J Clin Oncol 28:e401-e402; author reply e403
13. Hutter Jr AM, Kayhoe DE 1966 Adrenal cortical carcinoma. Clinical features of 138 patients. Am J Med 41:572-580
14. Luton JP, Cerdas S, Billaud L, Thomas G, Guilhaume B, Bertagna X, Laudat MH, Louvel A, Chapuis Y, Blondeau P, Bonnin A, Bricaire H 1990 Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 322:1195-1201
15. Sabolch A, Feng M, Griffith K, Hammer G, Doherty G, Ben-Josef E 2011 Adjuvant and definitive radiotherapy for adrenocortical carcinoma. Int J Radiat Oncol Biol Phys 80:1477-1484
16. Fassnacht M, Hahner S, Polat B, Koschker AC, Kenn W, Flentje M, Allolio B 2006 Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. J Clin Endocrinol Metab 91:4501-4504
17. Lee JE, Berger DH, el-Naggar AK, Hickey RC, Vassilopoulou-Sellin R, Gagel RF, Burgess MA, Evans DB 1995 Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. Surgery 118:1090-1098
18. Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, Terzolo M, Mueller HH, Hahner S, Allolio B 2009 Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM classification. Cancer 115:243-250
19. Polat B, Fassnacht M, Pfreundner L, Guckenberger M, Bratengeier K, Johanssen S, Kenn W, Hahner S, Allolio B, Flentje M 2009 Radiotherapy in adrenocortical carcinoma. Cancer 115:2816-2823
20. Kebebew E, Reiff E, Duh QY, Clark OH, McMillan A 2006 Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg 30:872-878
21. Markoe AM, Serber W, Micaily B, Brady LW 1991 Radiation therapy for adjunctive treatment of adrenal cortical carcinoma. Am J Clin Oncol 14:170-174
22. Percarpio B, Knowlton AH 1976 Radiation therapy of adrenal cortical carcinoma. Acta Radiol Ther Phys Biol 15:288-292
23. Magee BJ, Gattamaneni HR, Pearson D 1987 Adrenal cortical carcinoma: survival after radiotherapy. Clin Radiol 38:587-588
24. Venkatesh S, Hickey RC, Sellin RV, Fernandez JF, Samaan NA 1989 Adrenal cortical carcinoma. Cancer 64:765-769
25. Didolkar MS, Bescher RA, Elias EG, Moore RH 1981 Natural history of adrenal cortical carcinoma: a clinicopathologic study of 42 patients. Cancer 47:2153-2161
26. Gicquel C, Bertagna X, Gaston V, Coste J, Louvel A, Baudin E, Bertherat J, Chapuis Y, Duclos JM, Schlumberger M, Plouin PF, Luton JP, Le Bouc Y 2001 Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res 61:6762-6767
27. Morimoto R, Satoh F, Murakami O, Suzuki T, Abe T, Tanemoto M, Abe M, Uruno A, Ishidoya S, Arai Y, Takahashi K, Sasano H, Ito S 2008 Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas. Endocr J 55:49-55